![Praveen Malhotra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Praveen Malhotra
Technik-/Wissenschafts-/F&E-Leiter bei
TCR2 THERAPEUTICS INC.
Profil
Praveen Malhotra is currently working as Vice President-Information Technology at TCR2 Therapeutics, Inc. He previously worked as Head-Information Technology Operations at Voyager Therapeutics, Inc. He has a graduate degree from New Mexico State University and an undergraduate degree from Deenbandhu Chhotu Ram University of Science & Technology.
Aktive Positionen von Praveen Malhotra
| Unternehmen | Position | Beginn |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ehemalige bekannte Positionen von Praveen Malhotra
| Unternehmen | Position | Ende |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Praveen Malhotra
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
New Mexico State University
 New Mexico State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Deenbandhu Chhotu Ram University of Science & Technology
 Deenbandhu Chhotu Ram University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
